Matsumoto K, Osakabe K, Katayama H, Okano K, Watanabe S, Hatano M
Nephron. 1984;37(4):273-5. doi: 10.1159/000183263.
Cell-mediated immunity (CMI) was evaluated in 76 patients with renal disease by summation of delayed cutaneous hypersensitivity (DHS) responses to 4 test antigens, purified protein derivative (PPD), candida, mumps and keyhole limpet hemocyanin (KLH). Patients with lipoid nephrosis (LN) in the nephrotic stage had less mean induration of skin reactivity and a smaller proportion reacting to the former 3 antigens as compared with normal controls or LN patients without the nephrotic syndrome (NS). In contrast, the intensity of skin reactivity and the frequency of negative reactions in LN patients in remission and chronic mesangial proliferative glomerulonephritis (CGN) were similar to those of the control subjects. Immune response to KLH was also impaired in LN patients with the NS as measured by skin testing. The data indicate an impaired DHS in LN and suggest that the impairment relates to the clinical stage of disease.
通过对4种试验抗原,即纯化蛋白衍生物(PPD)、念珠菌、腮腺炎病毒和钥孔戚血蓝蛋白(KLH)的迟发性皮肤超敏反应(DHS)进行汇总,评估了76例肾病患者的细胞介导免疫(CMI)。与正常对照或无肾病综合征(NS)的脂性肾病(LN)患者相比,处于肾病阶段的脂性肾病患者皮肤反应性的平均硬结较小,对前3种抗原产生反应的比例也较小。相比之下,缓解期的LN患者和慢性系膜增生性肾小球肾炎(CGN)患者的皮肤反应强度和阴性反应频率与对照受试者相似。通过皮肤试验检测,患有NS的LN患者对KLH的免疫反应也受损。数据表明LN患者的DHS受损,提示这种损害与疾病的临床阶段有关。